Patrick Oledimmah
Psychiatric/Mental Health · Union, NJNPI 1518477504
Payments from drug & device makers
Across 187 payments — averaging $28.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alkermes, Inc.$2K
- AbbVie$1K
- Teva Pharmaceuticals USA, Inc.$517
- Neurocrine Biosciences, Inc.$414
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$373
- Otsuka America Pharmaceutical, Inc.$365
- plus $612 from 6 others
What the payments were for
- Food & beverage$5,25099%
- Education$471%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alkermes, Inc. | 71 | $1,922 |
| AbbVie | 46 | $1,094 |
| Teva Pharmaceuticals USA, Inc. | 7 | $517 |
| Neurocrine Biosciences, Inc. | 8 | $414 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 13 | $373 |
| Otsuka America Pharmaceutical, Inc. | 10 | $365 |
| E.r. Squibb & Sons, L.L.C. | 13 | $237 |
| Corium, LLC | 9 | $216 |
| Sunovion Pharmaceuticals Inc. | 4 | $77 |
| Johnson & Johnson | 4 | $53 |
| Indivior Inc. | 1 | $14 |
| Vanda Pharmaceuticals Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ARISTADA$1,746
- LYBALVI$1,455
- ARISTADA INITIO$437
- INGREZZA$363
- VRAYLAR$250
- UZEDY$125
- ABILIFY MAINTENA$125
- REXULTI$120
- CAPLYTA$117
- AUSTEDO$117
- Azstarys$114
- Austedo XR$112
How this compares
$5,297 in reported general payments places this provider in the 90th percentile of 1,212 psychiatric/mental health providers in New Jersey.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Chlorpromazine Hcl | 40 | $14,593 |
| Lamotrigine | 75 | $3,646 |
| Divalproex Sodium | 89 | $3,609 |
| Divalproex Sodium ErDivalproex Sodium | 46 | $2,290 |
| Paliperidone ErPaliperidone | 25 | $2,186 |
| Aripiprazole | 34 | $2,127 |
| Risperidone | 96 | $1,893 |
| Quetiapine Fumarate | 150 | $1,827 |
| Clonazepam | 174 | $1,679 |
| Perphenazine | 12 | $1,035 |
| Haloperidol | 32 | $1,031 |
| Sertraline Hcl | 149 | $908 |
| Levetiracetam | 19 | $871 |
| Olanzapine | 68 | $810 |
| Benztropine Mesylate | 58 | $800 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Union
- Kevin ObiUnion$11K
- Ubong UdofiaMarlton$407K
- Anthony DimuraRed Bank$130K
- Amy PinsenNewton$111K
- Aaron SpectorMarlton$100K
- Fiorella ParadisiSparta$84K
- Diane BurtBridgeton$81K
- Alta ManessHackensack$75K
- Laura LeahySewell$41K
- Linda WinfulMontclair$40K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.